ClearPoint Neuro Inc. (CLPT)
NASDAQ · Healthcare
ClearPoint Neuro Inc. EBITDA 2010–2025
ClearPoint Neuro Inc. annual/quarterly ebitda history and growth rate from 2010 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- ClearPoint Neuro Inc. ebitda for the quarter ending March 31, 2026 was -8.4 M, a 38.48% increase year-over-year.
- ClearPoint Neuro Inc. ebitda for the twelve months ending March 31, 2026 was -24.0 M, a 198.88% increase year-over-year.
- ClearPoint Neuro Inc. annual ebitda for 2025 was -23.4 M, a 24.51% increase from 2024.
- ClearPoint Neuro Inc. annual ebitda for 2024 was -18.8 M, a 14.05% decrease from 2023.
- ClearPoint Neuro Inc. annual ebitda for 2023 was -21.8 M, a 35.63% increase from 2022.
- ClearPoint Neuro Inc. annual ebitda for 2022 was -16.1 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
ClearPoint Neuro Inc. EBITDA — FAQ
ClearPoint Neuro Inc. (CLPT) ebitda over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CLPT's ebitda history?
The chart and table above show ClearPoint Neuro Inc.'s ebitda by year and by quarter, including the growth rate.